ELLIOTT ASSOCIATES LP
SC 13D/A, 2000-11-14
Previous: HARVEY ENTERTAINMENT CO, 10QSB, EX-27, 2000-11-14
Next: ELLIOTT ASSOCIATES LP, 3, 2000-11-14




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934

  INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND
               AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)

                               (Amendment No. 8)*

Vion Pharmaceuticals, Inc.
(Name of Issuer)

Common Stock, $.01 par value
(Title of Class of Securities)

927624106
(CUSIP Number)

Martin D. Sklar,  Esq.,  Kleinberg,  Kaplan,  Wolff & Cohen, P.C. 551 Fifth
Avenue,  New York,  New York  10176  Tel:  (212)  986-6000  (Name,  Address  and
Telephone Number of Person Authorized to Receive Notices and Communications)

November 13, 2000
(Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[ ].

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all  exhibits.  See Rule 13d-7(b) for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                       (Continued on the following pages)
                                  (Page 1 of 7)


<PAGE>



Page 8 of 7


1.       NAME OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                  Elliott Associates, L.P.

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
         (a)[x]
         (b)[ ]

3.       SEC USE ONLY

4.       SOURCE OF FUNDS*
                  WC

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
         ITEMS 2(d) or 2(e)  [  ]

6.       CITIZENSHIP OR PLACE OF ORGANIZATION
                  Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.       SOLE VOTING POWER
                  1,425,344

8        SHARED VOTING POWER
                  0

9.       SOLE DISPOSITIVE POWER
                  1,425,344

10.      SHARED DISPOSITIVE POWER
                  0

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                  1,425,344

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
         EXCLUDES CERTAIN SHARES*   [ ]

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  5.45%

14.      TYPE OF REPORTING PERSON*
                  PN

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>



1.       NAME OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                  Westgate International, L.P.

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
         (a)[x]
         (b)[ ]

3.       SEC USE ONLY

4.       SOURCE OF FUNDS*
                  WC

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
         REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     [ ]

6.       CITIZENSHIP OR PLACE OF ORGANIZATION
                  Cayman Islands, British West Indies

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.       SOLE VOTING POWER
                  0

8.       SHARED VOTING POWER
                  1,427,769

9.       SOLE DISPOSITIVE POWER
                  0

10.      SHARED DISPOSITIVE POWER
                  1,427,769

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
         REPORTING PERSON
                  1,427,769

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
         EXCLUDES CERTAIN SHARES*           [ ]

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  5.46%

14.      TYPE OF REPORTING PERSON*
                  PN

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>



1.       NAME OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
                  Elliott International Capital Advisors, Inc.

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
         (a)[x]
         (b)[ ]

3.       SEC USE ONLY

4.       SOURCE OF FUNDS*
                  00

5.       CHECK BOX IF DISCLOSURE OF LEGAL  PROCEEDINGS  IS REQUIRED  PURSUANT TO
         ITEMS 2(d) or 2(e)           [ ]

6.       CITIZENSHIP OR PLACE OF ORGANIZATION
                  Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH
REPORTING PERSON WITH

7.       SOLE VOTING POWER
                  0

8.       SHARED VOTING POWER
                  1,427,769

9.       SOLE DISPOSITIVE POWER
                  0

10.      SHARED DISPOSITIVE POWER
                  1,427,769

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
         REPORTING PERSON
                  1,427,769

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
         EXCLUDES CERTAIN SHARES*           [ ]

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  5.46%

14.      TYPE OF REPORTING PERSON*
                  CO

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>



         This  statement is filed  pursuant to Rule 13d-2(a) with respect to the
shares  of  common  stock,   $.01  par  value  (the  "Common   Stock")  of  Vion
Pharmaceuticals,  Inc. (the "Issuer")  beneficially owned by Elliott Associates,
L.P.  ("Elliott"),   Westgate  International,   L.P.  ("Westgate")  and  Elliott
International  Capital  Advisors,  Inc.  (f/k/a  Martley  International,   Inc.)
("International   Advisors,"  and  together  with  Elliott  and  Westgate,   the
"Reporting  Persons")  as of November  14, 2000 and amends and  supplements  the
Schedule 13D dated August 14, 1998,  as amended on September 3, 1998,  April 15,
1999, October 28, 1999,  February 22, 2000, March 9, 2000, April 7, 2000 and May
24, 2000 (the "Schedule 13D").  Except as set forth herein, the Schedule 13D, as
previously amended, is unmodified.

ITEM 3.  Source and Amount of Funds or Other Consideration.

         The source and amount of funds used by Elliott in making its  purchases
of the shares of Common Stock beneficially owned by it are set forth below:

SOURCE OF FUNDS                                      AMOUNT OF FUNDS
Working Capital                                      $7,383,854

         The source and amount of funds used by Westgate in making its purchases
of the shares of Common Stock beneficially owned by it are set forth below:

SOURCE OF FUNDS                                      AMOUNT OF FUNDS
Working Capital                                      $6,191,434

ITEM 5.  Interest in Securities of the Issuer.

         (a)  Elliott  beneficially  owns  1,425,344  shares  of  Common  Stock,
constituting 5.45% of all of the outstanding shares of Common Stock.

         Westgate and  International  Advisors  beneficially own an aggregate of
1,427,769 shares of Common Stock,  constituting  5.46% of all of the outstanding
shares of Common Stock.

         Collectively,   Elliott,   Westgate  and  International   Advisors  own
2,853,113 shares of Common Stock  constituting  10.91% of all of the outstanding
shares of Common Stock.

         (b) Elliott has the power to vote or direct the vote of, and to dispose
or direct the disposition of, the shares of Common Stock  beneficially  owned by
it.

         Westgate  has the shared power with  International  Advisors to vote or
direct the vote of, and to dispose or direct the  disposition  of, the shares of
Common  Stock owned by  Westgate.  Information  regarding  each of Westgate  and
International  Advisors  is set  forth  in  Item 2 of this  Schedule  13D and is
expressly incorporated by reference herein.

         (c) The following transactions were effected by Elliott during the past
sixty (60) days:

                                                     Approx. Price per
                                    Amount of Shs.   Share (excl. of
Date              Security          Bought (Sold)    commissions)

10/31/00          Common              5,400          $10.32
11/13/00          Common            125,000          $10.44

         Elliott effected the above transactions on NASDAQ.

         The following  transactions  were effected by Westgate  during the past
sixty (60) days:

                                                     Approx. Price per
                                    Amount of Shs.   Share (excl. of
Date              Security          Bought (Sold)    commissions)

10/31/00          Common              5,400          $10.32
11/13/00          Common            125,000          $10.44

         Westgate effected the above transactions on NASDAQ.

         No other  transactions  were  effected  by either  Elliott or  Westgate
during the past sixty (60) days.

         (d) No person  other than Elliott has the right to receive or the power
to direct the receipt of dividends  from,  or the proceeds from the sale of, the
shares of Common Stock beneficially owned by Elliott.

         No person other than Westgate and International  Advisors has the right
to receive or the power to direct the receipt of dividends from, or the proceeds
from the sale of, the shares of Common Stock  beneficially owned by Westgate and
International Advisors.

         (e)      Not applicable.



<PAGE>




                                   SIGNATURES

         After  reasonable  inquiry and to the best of its knowledge and belief,
the undersigned each certifies that the information with respect to it set forth
in this statement is true, complete and correct.

Dated: November 14, 2000

                                    ELLIOTT ASSOCIATES, L.P.
                                    By:  Elliott Capital Advisors, L.P., as
                                            General Partner

                                           By: Braxton Associates, Inc., as
                                           General Partner


                                             By: /s/ Elliot Greenberg
                                                      Elliot Greenberg
                                                      Vice President

                                    WESTGATE INTERNATIONAL, L.P.
                                    By: Elliott International Capital Advisors,
                                          Inc., as Attorney-in-Fact


                                             By: /s/ Elliot Greenberg
                                                              Elliot Greenberg
                                                              Vice President

                                    ELLIOTT INTERNATIONAL CAPITAL ADVISORS, INC.


                                            By: /s/ Elliot Greenberg
                                                     Elliot Greenberg
                                                     Vice President


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission